R&D Scientists and algorithms: Finding the right balance in mode... The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Views & Analysis Expanding data sources: faster drug development? Using advanced technology and the skills of the data scientist to manage data from diverse sources.
News Beacon's XLRP gene therapy set for filing after phase 3 win Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
